Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Jan 22, 2018 3:19pm
326 Views
Post# 27410598

RE:RE:RE:Biotech Takeovers

RE:RE:RE:Biotech Takeovers
Transit77 wrote: It better not be sold for less than $20 I want minimum $50 and that better be a reality. Some people have been waiting 10 plus years let’s see $50 and call it a day. 


OMFG pass me a Gaviscon - I am bloated from so much pumping... LOL. I like 97% of shareholders would sell in a heartbeat for $3-$4 no problem, yet you want a 3000% premium... FDesloges pump fest much??? LOL
Bullboard Posts